The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antipsychotics-Global Market Insights and Sales Trends 2025
Synopsis
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
The global Antipsychotics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antipsychotics in various end use industries. The expanding demands from the Schizophrenia, Bipolar Disorder, Unipolar Depression and Dementia, are propelling Antipsychotics market. First Generation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Second Generation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antipsychotics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antipsychotics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antipsychotics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antipsychotics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antipsychotics covered in this report include Johnson & Johnson, Pfizer, Eli Lilly & Co, Bristol-Myers Squibb, AstraZeneca, Glaxo SmithKline and Allergan, etc.
The global Antipsychotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Pfizer
Eli Lilly & Co
Bristol-Myers Squibb
AstraZeneca
Glaxo SmithKline
Allergan
Global Antipsychotics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antipsychotics market, Segment by Type:
First Generation
Second Generation
Third Generation
Global Antipsychotics market, by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antipsychotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antipsychotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
The global Antipsychotics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antipsychotics in various end use industries. The expanding demands from the Schizophrenia, Bipolar Disorder, Unipolar Depression and Dementia, are propelling Antipsychotics market. First Generation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Second Generation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antipsychotics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antipsychotics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antipsychotics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antipsychotics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antipsychotics covered in this report include Johnson & Johnson, Pfizer, Eli Lilly & Co, Bristol-Myers Squibb, AstraZeneca, Glaxo SmithKline and Allergan, etc.
The global Antipsychotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Pfizer
Eli Lilly & Co
Bristol-Myers Squibb
AstraZeneca
Glaxo SmithKline
Allergan
Global Antipsychotics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antipsychotics market, Segment by Type:
First Generation
Second Generation
Third Generation
Global Antipsychotics market, by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antipsychotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antipsychotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antipsychotics Market Overview
1.1 Antipsychotics Product Overview
1.2 Antipsychotics Market Segment by Type
1.2.1 First Generation
1.2.2 Second Generation
1.2.3 Third Generation
1.3 Global Antipsychotics Market Size by Type
1.3.1 Global Antipsychotics Market Size Overview by Type (2018-2029)
1.3.2 Global Antipsychotics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antipsychotics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antipsychotics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antipsychotics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antipsychotics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antipsychotics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antipsychotics Sales Breakdown by Type (2018-2023)
2 Global Antipsychotics Market Competition by Company
2.1 Global Top Players by Antipsychotics Sales (2018-2023)
2.2 Global Top Players by Antipsychotics Revenue (2018-2023)
2.3 Global Top Players by Antipsychotics Price (2018-2023)
2.4 Global Top Manufacturers Antipsychotics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antipsychotics Market Competitive Situation and Trends
2.5.1 Antipsychotics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antipsychotics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antipsychotics as of 2022)
2.7 Date of Key Manufacturers Enter into Antipsychotics Market
2.8 Key Manufacturers Antipsychotics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antipsychotics Status and Outlook by Region
3.1 Global Antipsychotics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antipsychotics Historic Market Size by Region
3.2.1 Global Antipsychotics Sales in Volume by Region (2018-2023)
3.2.2 Global Antipsychotics Sales in Value by Region (2018-2023)
3.2.3 Global Antipsychotics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antipsychotics Forecasted Market Size by Region
3.3.1 Global Antipsychotics Sales in Volume by Region (2024-2029)
3.3.2 Global Antipsychotics Sales in Value by Region (2024-2029)
3.3.3 Global Antipsychotics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antipsychotics by Application
4.1 Antipsychotics Market Segment by Application
4.1.1 Schizophrenia
4.1.2 Bipolar Disorder
4.1.3 Unipolar Depression
4.1.4 Dementia
4.1.5 Others
4.2 Global Antipsychotics Market Size by Application
4.2.1 Global Antipsychotics Market Size Overview by Application (2018-2029)
4.2.2 Global Antipsychotics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antipsychotics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antipsychotics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antipsychotics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antipsychotics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antipsychotics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antipsychotics Sales Breakdown by Application (2018-2023)
5 North America Antipsychotics by Country
5.1 North America Antipsychotics Historic Market Size by Country
5.1.1 North America Antipsychotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antipsychotics Sales in Volume by Country (2018-2023)
5.1.3 North America Antipsychotics Sales in Value by Country (2018-2023)
5.2 North America Antipsychotics Forecasted Market Size by Country
5.2.1 North America Antipsychotics Sales in Volume by Country (2024-2029)
5.2.2 North America Antipsychotics Sales in Value by Country (2024-2029)
6 Europe Antipsychotics by Country
6.1 Europe Antipsychotics Historic Market Size by Country
6.1.1 Europe Antipsychotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antipsychotics Sales in Volume by Country (2018-2023)
6.1.3 Europe Antipsychotics Sales in Value by Country (2018-2023)
6.2 Europe Antipsychotics Forecasted Market Size by Country
6.2.1 Europe Antipsychotics Sales in Volume by Country (2024-2029)
6.2.2 Europe Antipsychotics Sales in Value by Country (2024-2029)
7 Asia-Pacific Antipsychotics by Region
7.1 Asia-Pacific Antipsychotics Historic Market Size by Region
7.1.1 Asia-Pacific Antipsychotics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antipsychotics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antipsychotics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antipsychotics Forecasted Market Size by Region
7.2.1 Asia-Pacific Antipsychotics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antipsychotics Sales in Value by Region (2024-2029)
8 Latin America Antipsychotics by Country
8.1 Latin America Antipsychotics Historic Market Size by Country
8.1.1 Latin America Antipsychotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antipsychotics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antipsychotics Sales in Value by Country (2018-2023)
8.2 Latin America Antipsychotics Forecasted Market Size by Country
8.2.1 Latin America Antipsychotics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antipsychotics Sales in Value by Country (2024-2029)
9 Middle East and Africa Antipsychotics by Country
9.1 Middle East and Africa Antipsychotics Historic Market Size by Country
9.1.1 Middle East and Africa Antipsychotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antipsychotics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antipsychotics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antipsychotics Forecasted Market Size by Country
9.2.1 Middle East and Africa Antipsychotics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antipsychotics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Antipsychotics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Antipsychotics Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Antipsychotics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Antipsychotics Products Offered
10.2.5 Pfizer Recent Development
10.3 Eli Lilly & Co
10.3.1 Eli Lilly & Co Company Information
10.3.2 Eli Lilly & Co Introduction and Business Overview
10.3.3 Eli Lilly & Co Antipsychotics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly & Co Antipsychotics Products Offered
10.3.5 Eli Lilly & Co Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Antipsychotics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bristol-Myers Squibb Antipsychotics Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Antipsychotics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Antipsychotics Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Glaxo SmithKline
10.6.1 Glaxo SmithKline Company Information
10.6.2 Glaxo SmithKline Introduction and Business Overview
10.6.3 Glaxo SmithKline Antipsychotics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Glaxo SmithKline Antipsychotics Products Offered
10.6.5 Glaxo SmithKline Recent Development
10.7 Allergan
10.7.1 Allergan Company Information
10.7.2 Allergan Introduction and Business Overview
10.7.3 Allergan Antipsychotics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Allergan Antipsychotics Products Offered
10.7.5 Allergan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antipsychotics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antipsychotics Industrial Chain Analysis
11.4 Antipsychotics Market Dynamics
11.4.1 Antipsychotics Industry Trends
11.4.2 Antipsychotics Market Drivers
11.4.3 Antipsychotics Market Challenges
11.4.4 Antipsychotics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antipsychotics Distributors
12.3 Antipsychotics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
